Transcath Therapeutics LLP

Transcath Therapeutics LLP - pharma in Surat, Gujarat, India. Directors, charges & compliance details.
LLPIN AAF-8674 Incorporated 07 March 2016 ROC Ahmedabad HQ Surat, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹5 Lakh
As per LLP agreement
LLP age
10 yrs
Est. 2016
Designated partners
2
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2024
Balance sheet date
LLP status
Active
MCA master data
Registrar
Ahmedabad
ROC office
Incorporated
07 Mar 2016
Date of incorporation

About Transcath Therapeutics LLP

Data last updated:

Transcath Therapeutics LLP is a limited liability partnership (LLP) based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAF-8674. The LLP has 1 GST registration on record, which is no longer active.

The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners Parth Rajesh Vaishnav and Rajesh Laljibhai Vaishnav.

Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Surat, Gujarat.

Company Details of Transcath Therapeutics LLP
LLPIN AAF-8674
Incorporation Date 07 March 2016
Total Obligation of Contribution ₹5 Lakh
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    D – 54/2 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Transcath Therapeutics LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Transcath Therapeutics LLP report

Financials, compliance, directors, charges, ownership and filings for Transcath Therapeutics LLP in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Financials of Transcath Therapeutics LLP FY 2024 filings available

Financial Statement Summary of Transcath Therapeutics LLP

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Transcath Therapeutics LLP

Statement of Account and SolvencyFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Transcath Therapeutics are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Transcath Therapeutics LLP

Transcath Therapeutics has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Parth Rajesh VaishnavDesignated Partner07 Mar 201610 Years 7 MonthsCurrent
Rajesh Laljibhai VaishnavDesignated Partner07 Mar 201610 Years 7 MonthsCurrent

Charges & Borrowings of Transcath Therapeutics LLP

Transcath Therapeutics LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Transcath Therapeutics LLP

Employment history and EPFO contributions of people linked to Transcath Therapeutics.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Transcath Therapeutics LLP

Transcath Therapeutics LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Parth Rajesh Vaishnav was appointed as Designated Partner on 07 Mar 2016.

AGM
Transcath Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Transcath Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Appointed
Parth Rajesh Vaishnav was appointed as Designated Partner.
Appointed
Rajesh Laljibhai Vaishnav was appointed as Designated Partner.
Incorporation
07 Mar 2016
Transcath Therapeutics Llp was registered on 07 Mar 2016 with Roc Ahmedabad & aged 10 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Transcath Therapeutics LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Transcath Therapeutics LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Transcath Therapeutics LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Transcath Therapeutics LLP

Transcath Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Transcath Therapeutics LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Transcath Therapeutics LLP

Transcath Therapeutics is an active limited liability partnership based in Surat, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 2016 (10+ years old) and is registered under LLPIN AAF-8674.

Transcath Therapeutics has 2 current designated partners:

No. Transcath Therapeutics has 1 GST registration on record and it is cancelled or inactive.

The LLPIN (Limited Liability Partnership Identification Number) of Transcath Therapeutics is AAF-8674. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Transcath Therapeutics was incorporated on 07 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Parth Rajesh Vaishnav was appointed as Designated Partner on 07 Mar 2016. Rajesh Laljibhai Vaishnav was appointed as Designated Partner on 07 Mar 2016.

The registered office of Transcath Therapeutics is at D – 542 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230.

The total obligation of contribution is ₹5 Lakh.

Transcath Therapeutics operates in the pharma industry, in the drug formulation and development segment.

Transcath Therapeutics can be reached at its registered office: D – 542 Hojiwala Ind. Estate Road No. 23 Nr. Gate No. 3 Sachin Palsana Highway, Sachin, Surat, Gujarat, India – 394230.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available